Clinical Trial Update: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a regimen of oxaliplatin, fludarabine, cytarabine, and rituximab in patients with Richter's syndrome and leukemia; the trial is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Richter Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• OXALIPLATIN (Oxaliplatin)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Richter's Transformation, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-11-26